Transcriptional activation inhibitory protein
US7250488B1 · kind B1 · utility
2Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2000 |
| Grant date | Jul 31, 2007 |
| Priority date | — |
| Expiry date | Apr 26, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A protein binding to β-catenin and thus inhibiting the transcriptional activation induced by the formation of a complex of β-catenin with a protein belonging to the TCF/Lef family; a DNA encoding this protein; an antibody recognizing this protein; a therapeutic agent containing the above protein or DNA; and a diagnostic agent containing the above antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.